Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Relypsa reports data on part A of its phase III patiromer trial

Sep. 16, 2013

ChemoCentryx reports interim data for CCX-140 in patients with diabetic nephropathy

Sep. 13, 2013

Genkyotex obtains IND approval for phase II study of GKT-137831

Sep. 9, 2013

Rockwell Medical reports findings from CRUISE-2 study of SFP

Sep. 5, 2013

Swissmedic opposes approval of Vitaros

Sep. 3, 2013

Fedovapagon tested as potential therapy for nocturia associated with BPH

Sep. 2, 2013

Pilocarpine/tolterodine fixed-dose combination is well tolerated at increased total daily doses

Sep. 2, 2013

FDA issues tolvaptan CRL for kidney disease

Aug. 30, 2013

FDA extends PDUFA goal date for Xiaflex

Aug. 29, 2013

TRPM8 blockade as a potential new treatment strategy for urinary bladder disorders

Aug. 29, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...